{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:03Z","timestamp":1756316403067,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,25]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Following a minor meniscal injury to his right knee, a previously fit and well 58-year-old man developed profound somatisation leading to paraplegia. The patient developed a deep-seated belief that any exercise or walking would cause irreparable damage to his knee. Over the course of 2 years his, mobility reduced from active mountaineering to walking a short distance, and finally to paraplegia. Medical investigations were normal and organic causes were ruled out. Conventional therapy was exhausted, a number of medications were trialled over 5\u2009years, including selective serotonin reuptake inhibitors (SSRIs) and antipsychotics without success. Eventually, with a combination of cognitive behavioural therapy, physiotherapy and a novel experimental therapy where the patient rolled dice and acted according to the roll results, the patient was able to literally and metaphorically get back on his feet.<\/jats:p>","DOI":"10.1136\/bcr-2018-227285","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T13:25:36Z","timestamp":1634131536000},"page":"e227285","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Curing somatisation-induced paraplegia with experimental dice-based affective modulation"],"prefix":"10.1136","volume":"14","author":[{"given":"Miles Alexander William","family":"Rogers","sequence":"first","affiliation":[{"name":"General Medicine, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK"},{"name":"Psychiatry, Royal Oldham Hospital, Oldham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Au Yeung","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Guy's and St Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"2025082710034293000_14.10.e227285.1","unstructured":"International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for ;2016 [Internet]. 2016. Neurotic, stress-related and somatoform disorders (F40-F48) 2016, 2021. Available: https:\/\/icd.who.int\/browse10\/2016\/en#\/F40-F48"},{"key":"2025082710034293000_14.10.e227285.2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16020189"},{"key":"2025082710034293000_14.10.e227285.3","first-page":"VE01-VE04","article-title":"Validity of current treatment protocols to overcome hypochondriasis","volume":"11","author":"Khare","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"2025082710034293000_14.10.e227285.4","unstructured":"Neziroglu F . Hypochondriasis: a fresh outlook on treatment. Psychiatric Times, 1998."},{"key":"2025082710034293000_14.10.e227285.5","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(91)90082-4"},{"key":"2025082710034293000_14.10.e227285.6","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.153.1.129a","article-title":"Fear of AIDS","volume":"153","author":"Kamlana","year":"1988","journal-title":"Br J Psychiatry"},{"key":"2025082710034293000_14.10.e227285.7","first-page":"200","article-title":"Treatment of hypochondriasis with clomipramine","volume":"54","author":"Stone","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"2025082710034293000_14.10.e227285.8","unstructured":"Fallon BA , Liebowitz MR , Schneier F . An open trial of fluoxetine for hypochondriasis. Paper presented at the American Psychiatric Association Meeting New Orleans; May, 1991."},{"key":"2025082710034293000_14.10.e227285.9","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.148.8.1090a","article-title":"Treatment of cancer phobia with fluoxetine","volume":"148","author":"Viswanathan","year":"1991","journal-title":"Am J Psychiatry"},{"key":"2025082710034293000_14.10.e227285.10","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(86)90045-5"},{"key":"2025082710034293000_14.10.e227285.11","doi-asserted-by":"publisher","DOI":"10.1586\/erp.12.67"},{"key":"2025082710034293000_14.10.e227285.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.janxdis.2015.05.008","article-title":"Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial","volume":"34","author":"Weck","year":"2015","journal-title":"J Anxiety Disord"},{"key":"2025082710034293000_14.10.e227285.13","article-title":"Psychotherapies for hypochondriasis","volume":"2007","author":"Thomson","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:03:52Z","timestamp":1756314232000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,13]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bcr-2018-227285"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227285","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}